These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1738419)

  • 1. Intraglomerular proteinase activity in adriamycin-induced nephropathy.
    Paczek L; Teschner M; Schaefer RM; Kovar J; Romen W; Heidland A
    Nephron; 1992; 60(1):81-6. PubMed ID: 1738419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of renal disease on glomerular proteinases.
    Teschner M; Schaefer RM; Paczek L; Heidland A
    Miner Electrolyte Metab; 1992; 18(2-5):92-6. PubMed ID: 1465087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of disease on glomerular proteinases.
    Teschner M; Schaefer RM; Paczek L; Heidland A
    Przegl Lek; 1992; 49(1-2):1-5. PubMed ID: 1454996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obese Zucker rat: potential role of intraglomerular proteolytic enzymes in the development of glomerulosclerosis.
    Teschner M; Paczek L; Schaefer RM; Heidland A
    Res Exp Med (Berl); 1991; 191(2):129-35. PubMed ID: 1857891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin ameliorates depressed intraglomerular proteolytic activities in experimental nephrotic syndrome.
    Teschner M; Paczek L; Schaefer L; Bahner U; Heidland A; Schaefer RM
    Res Exp Med (Berl); 1994; 194(6):349-56. PubMed ID: 7716342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase activity in isolated glomeruli of Goldblatt hypertensive rats.
    Paczek L; Teschner M; Schaefer RM; Kovar J; Romen W; Heidland A
    Clin Exp Hypertens A; 1991; 13(3):339-56. PubMed ID: 1893609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glomerular proteinases in the evolution of glomerulosclerosis.
    Schaefer RM; Paczek L; Huang S; Teschner M; Schaefer L; Heidland A
    Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):641-6. PubMed ID: 1493156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary protein, angiotensin I converting enzyme inhibition and mesangial overload on the progression of adriamycin-induced nephropathy.
    Barretti P; Viero RM; Soares VA
    Braz J Med Biol Res; 1995 Jan; 28(1):39-50. PubMed ID: 7581027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events.
    Wang Y; Wang YP; Tay YC; Harris DC
    Kidney Int; 2000 Oct; 58(4):1797-804. PubMed ID: 11012915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-CT imaging and structural analysis of glomeruli in a model of Adriamycin-induced nephropathy.
    Xie L; Koukos G; Barck K; Foreman O; Lee WP; Brendza R; Eastham-Anderson J; McKenzie BS; Peterson A; Carano RAD
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F76-F89. PubMed ID: 30256127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adriamycin-induced focal glomerular sclerosis: pathogenetic development and alteration of glomerular epithelial cells].
    Ito K; Ger YC
    Nihon Jinzo Gakkai Shi; 1985 Aug; 27(8):1113-22. PubMed ID: 4087532
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.
    Lee VW; Harris DC
    Nephrology (Carlton); 2011 Jan; 16(1):30-8. PubMed ID: 21175974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
    Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
    J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.
    Fries JW; Sandstrom DJ; Meyer TW; Rennke HG
    Lab Invest; 1989 Feb; 60(2):205-18. PubMed ID: 2915515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease.
    Okuda S; Oh Y; Tsuruda H; Onoyama K; Fujimi S; Fujishima M
    Kidney Int; 1986 Feb; 29(2):502-10. PubMed ID: 3486312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protective role for programmed death 1 in progression of murine adriamycin nephropathy.
    Qin XH; Lee VW; Wang YP; Zheng GP; Wang Y; Alexander SI; Harris DC
    Kidney Int; 2006 Oct; 70(7):1244-50. PubMed ID: 16900095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin-induced glomerulosclerosis in the rat.
    Bertani T; Rocchi G; Sacchi G; Mecca G; Remuzzi G
    Am J Kidney Dis; 1986 Jan; 7(1):12-9. PubMed ID: 3510531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of Na+/H+ exchanger in the injured renal tissues of focal glomerulosclerosis in rats.
    Okuda S; Tamaki K; Ando T; Nagashima A; Nakayama M; Fukuda K; Higashi H; Fujishima M
    Kidney Int; 1994 Dec; 46(6):1635-43. PubMed ID: 7700022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
    Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
    Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular morphometry of adriamycin-induced focal and segmental glomerulosclerosis in the rat.
    Güezmes A; Fernández F; Garijo F; Val-Bernal F
    Am J Nephrol; 1992; 12(6):437-41. PubMed ID: 1292343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.